TAMMY BALAMUT: Open Payments
NPI 1255696811 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,162 in 106 payments from 14 companies in 2025. Trend: 2023 $531 · 2024 $517 · 2025 $2,162
Food & beverage: $2,162
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 32 | $719 |
| Axsome Therapeutics, Inc. | 16 | $256 |
| ABBVIE INC. | 12 | $223 |
| Otsuka America Pharmaceutical, Inc. | 9 | $161 |
| E.R. Squibb & Sons, L.L.C. | 9 | $158 |
| Neurocrine BioSciences, Inc. | 5 | $142 |
| Janssen Pharmaceuticals, Inc | 5 | $122 |
| Biogen, Inc. | 5 | $103 |
| Braeburn Inc. | 5 | $93 |
| Lundbeck LLC | 3 | $83 |
Products named: CAPLYTA, Auvelity, REXULTI, VRAYLAR, COBENFY, INGREZZA, ZURZUVAE, BRIXADI.
Industry payments across NY — which companies pay providers there.
